Racial differences in clinical trial perceptions among a large, predominantly Black cohort of people with systemic lupus erythematosus in the Southeastern USA
Objective Black people in the USA have a higher incidence and severity of SLE and worse outcomes, yet they are significantly under-represented in SLE clinical trials. We assessed racial differences in clinical trial perceptions among a large cohort of predominantly Black people with SLE.Methods Geor...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-01-01
|
| Series: | Lupus Science and Medicine |
| Online Access: | https://lupus.bmj.com/content/12/1/e001357.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841560045754515456 |
|---|---|
| author | Gaobin Bao Cristina Drenkard Charmayne Dunlop-Thomas Sung Sam Lim Kim Schofield Jessica Nicole Williams Hilton Mozee |
| author_facet | Gaobin Bao Cristina Drenkard Charmayne Dunlop-Thomas Sung Sam Lim Kim Schofield Jessica Nicole Williams Hilton Mozee |
| author_sort | Gaobin Bao |
| collection | DOAJ |
| description | Objective Black people in the USA have a higher incidence and severity of SLE and worse outcomes, yet they are significantly under-represented in SLE clinical trials. We assessed racial differences in clinical trial perceptions among a large cohort of predominantly Black people with SLE.Methods Georgians Organised Against Lupus (GOAL) is a population-based, prospective cohort of people with a validated diagnosis of SLE living in Atlanta. The 2021–2022 GOAL survey included questions assessing knowledge, perceptions and experiences of lupus clinical trials involving drug therapy. Self-reported race was categorised as Black or non-Black. Survey responses by race were compared using χ2 analyses. Among Black respondents, factors associated with willingness to participate in clinical trials were examined using univariable logistic regression.Results A total of 767 individuals responded to the 2021–2022 GOAL survey, of whom 80% were Black. There were 720 female respondents and 47 male respondents. There was no significant difference in willingness to participate in clinical trials between Black and non-Black respondents (28% vs 31%, p=0.071). Black respondents were less likely to correctly identify the definition of a clinical trial (34% vs 70%, p<0.001). Male gender, unemployed or disabled status, governmental health insurance and higher disease activity were associated with willingness to participate in clinical trials among Black respondents.Conclusions We found that only 28% of respondents were willing to participate in lupus clinical trials, with no difference by race. Efforts must continue to engage those resistant to trial participation, regardless of race. Our findings also indicate that further research is warranted to assess whether strategies such as clinical trial education and diversification of study staff may be helpful to increase Black patient recruitment. Sociodemographic factors (gender, work status, insurance status) and disease-related factors (lupus activity) may also play important roles in clinical trial participation among Black people. |
| format | Article |
| id | doaj-art-8114671dbd4a44b7864538f93d992e92 |
| institution | Kabale University |
| issn | 2053-8790 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | Lupus Science and Medicine |
| spelling | doaj-art-8114671dbd4a44b7864538f93d992e922025-01-05T05:00:10ZengBMJ Publishing GroupLupus Science and Medicine2053-87902025-01-0112110.1136/lupus-2024-001357Racial differences in clinical trial perceptions among a large, predominantly Black cohort of people with systemic lupus erythematosus in the Southeastern USAGaobin Bao0Cristina Drenkard1Charmayne Dunlop-Thomas2Sung Sam Lim3Kim Schofield4Jessica Nicole Williams5Hilton Mozee6Division of Rheumatology, Emory University, Atlanta, Georgia, USADivision of Rheumatology, Emory University, Atlanta, Georgia, USADivision of Rheumatology, Emory University, Atlanta, Georgia, USADivision of Rheumatology, Emory University, Atlanta, Georgia, USADivision of Rheumatology, Emory University, Atlanta, Georgia, USAWashington University School of Medicine in Saint Louis, St Louis, Missouri, USADivision of Rheumatology, Emory University, Atlanta, Georgia, USAObjective Black people in the USA have a higher incidence and severity of SLE and worse outcomes, yet they are significantly under-represented in SLE clinical trials. We assessed racial differences in clinical trial perceptions among a large cohort of predominantly Black people with SLE.Methods Georgians Organised Against Lupus (GOAL) is a population-based, prospective cohort of people with a validated diagnosis of SLE living in Atlanta. The 2021–2022 GOAL survey included questions assessing knowledge, perceptions and experiences of lupus clinical trials involving drug therapy. Self-reported race was categorised as Black or non-Black. Survey responses by race were compared using χ2 analyses. Among Black respondents, factors associated with willingness to participate in clinical trials were examined using univariable logistic regression.Results A total of 767 individuals responded to the 2021–2022 GOAL survey, of whom 80% were Black. There were 720 female respondents and 47 male respondents. There was no significant difference in willingness to participate in clinical trials between Black and non-Black respondents (28% vs 31%, p=0.071). Black respondents were less likely to correctly identify the definition of a clinical trial (34% vs 70%, p<0.001). Male gender, unemployed or disabled status, governmental health insurance and higher disease activity were associated with willingness to participate in clinical trials among Black respondents.Conclusions We found that only 28% of respondents were willing to participate in lupus clinical trials, with no difference by race. Efforts must continue to engage those resistant to trial participation, regardless of race. Our findings also indicate that further research is warranted to assess whether strategies such as clinical trial education and diversification of study staff may be helpful to increase Black patient recruitment. Sociodemographic factors (gender, work status, insurance status) and disease-related factors (lupus activity) may also play important roles in clinical trial participation among Black people.https://lupus.bmj.com/content/12/1/e001357.full |
| spellingShingle | Gaobin Bao Cristina Drenkard Charmayne Dunlop-Thomas Sung Sam Lim Kim Schofield Jessica Nicole Williams Hilton Mozee Racial differences in clinical trial perceptions among a large, predominantly Black cohort of people with systemic lupus erythematosus in the Southeastern USA Lupus Science and Medicine |
| title | Racial differences in clinical trial perceptions among a large, predominantly Black cohort of people with systemic lupus erythematosus in the Southeastern USA |
| title_full | Racial differences in clinical trial perceptions among a large, predominantly Black cohort of people with systemic lupus erythematosus in the Southeastern USA |
| title_fullStr | Racial differences in clinical trial perceptions among a large, predominantly Black cohort of people with systemic lupus erythematosus in the Southeastern USA |
| title_full_unstemmed | Racial differences in clinical trial perceptions among a large, predominantly Black cohort of people with systemic lupus erythematosus in the Southeastern USA |
| title_short | Racial differences in clinical trial perceptions among a large, predominantly Black cohort of people with systemic lupus erythematosus in the Southeastern USA |
| title_sort | racial differences in clinical trial perceptions among a large predominantly black cohort of people with systemic lupus erythematosus in the southeastern usa |
| url | https://lupus.bmj.com/content/12/1/e001357.full |
| work_keys_str_mv | AT gaobinbao racialdifferencesinclinicaltrialperceptionsamongalargepredominantlyblackcohortofpeoplewithsystemiclupuserythematosusinthesoutheasternusa AT cristinadrenkard racialdifferencesinclinicaltrialperceptionsamongalargepredominantlyblackcohortofpeoplewithsystemiclupuserythematosusinthesoutheasternusa AT charmaynedunlopthomas racialdifferencesinclinicaltrialperceptionsamongalargepredominantlyblackcohortofpeoplewithsystemiclupuserythematosusinthesoutheasternusa AT sungsamlim racialdifferencesinclinicaltrialperceptionsamongalargepredominantlyblackcohortofpeoplewithsystemiclupuserythematosusinthesoutheasternusa AT kimschofield racialdifferencesinclinicaltrialperceptionsamongalargepredominantlyblackcohortofpeoplewithsystemiclupuserythematosusinthesoutheasternusa AT jessicanicolewilliams racialdifferencesinclinicaltrialperceptionsamongalargepredominantlyblackcohortofpeoplewithsystemiclupuserythematosusinthesoutheasternusa AT hiltonmozee racialdifferencesinclinicaltrialperceptionsamongalargepredominantlyblackcohortofpeoplewithsystemiclupuserythematosusinthesoutheasternusa |